Nj. Welsh et al., APPLICATION OF A MODEL TO EXPLORE INTERSPECIES DIFFERENCES IN ACETYLCHOLINE M-RECEPTOR-STIMULATED GASTRIC-ACID SECRETION, British Journal of Pharmacology, 115(6), 1995, pp. 961-968
1 Concentration-effect curves were obtained, in the absence and presen
ce of histamine H-2-receptor blockade, to 5-methylfurmethide (5-MeF) a
nd McN-A 343, high efficacy and low efficacy acetylcholine (ACh) M-rec
eptor agonists, respectively, in isolated stomach preparations from th
e mouse and immature rat and guinea-pig. 2 In the immature guinea-pig
assay, the responses to 5-MeF and McN-A 343 were abolished by histamin
e H-2-receptor blockade suggesting that the responses were totally dep
endent upon gastric mucosal histamine. However, in the mouse and immat
ure rat assays, although the histamine H-2-receptor antagonists produc
ed small but significant rightward shifts and, in some cases, depressi
on of the maximum of the agonist concentration-effect curves, a signif
icant secretory response remained, presumed to be due to direct stimul
ation of oxyntic cells. 3 Previously, by assuming that the histamine H
-2-receptor blockade alters the mode of agonist-stimulated acid secret
ion from mainly an indirect action mediated by histamine release to di
rect stimulation of the oxyntic cell, we applied an operational model
of agonism to similar data obtained in the mouse preparation. In that
study we were able to account for the behaviour of 5-MeF and McN-A 343
by assuming that the agonists expressed 6 fold higher efficacy, tau i
n the operational model of agonism, at ACh M-receptors on the histamin
e-releasing cells than on the oxyntic cells. In this study it was poss
ible to account for the variation in the behaviour of the agonists bot
h between and within assays by simply varying the efficacy expressed b
y the agonists at each of the cells in the model. The efficacy variati
on could be due to receptor concentration variation. 4 The data and an
alysis are discussed in terms of contemporary models for the role of h
istamine in the regulation of gastric acid secretion.